“The first line of treatment is the use of corticosteroids. Unfortunately, steroids in their prolonged use have a series of side effects that can lead to real pathological manifestations or can have demonstrations with a high impact on the patient’s quality of life “. This was stated by Valerio De Stefano, Director of UOC, Service and DH Hematology of the Gemelli Polyclinic, on the sidelines of the event “Primary Immune Thrombocytopenia: changing the approach to change your life”, promoted by Inrete with the non-conditioning contribution of Novartis.
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘415374439673532’);
fbq(‘track’, ‘PageView’);